Incyte Revenue 2010-2025 | INCY

Incyte annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Incyte revenue for the quarter ending March 31, 2025 was $1.053B, a 19.53% increase year-over-year.
  • Incyte revenue for the twelve months ending March 31, 2025 was $4.413B, a 17.13% increase year-over-year.
  • Incyte annual revenue for 2024 was $4.241B, a 14.76% increase from 2023.
  • Incyte annual revenue for 2023 was $3.696B, a 8.87% increase from 2022.
  • Incyte annual revenue for 2022 was $3.395B, a 13.67% increase from 2021.
Incyte Annual Revenue
(Millions of US $)
2024 $4,241
2023 $3,696
2022 $3,395
2021 $2,986
2020 $2,667
2019 $2,159
2018 $1,882
2017 $1,536
2016 $1,106
2015 $754
2014 $511
2013 $355
2012 $297
2011 $94
2010 $170
2009 $9
Incyte Quarterly Revenue
(Millions of US $)
2025-03-31 $1,053
2024-12-31 $1,179
2024-09-30 $1,138
2024-06-30 $1,044
2024-03-31 $881
2023-12-31 $1,013
2023-09-30 $919
2023-06-30 $955
2023-03-31 $809
2022-12-31 $927
2022-09-30 $823
2022-06-30 $911
2022-03-31 $733
2021-12-31 $863
2021-09-30 $813
2021-06-30 $706
2021-03-31 $605
2020-12-31 $790
2020-09-30 $621
2020-06-30 $688
2020-03-31 $569
2019-12-31 $579
2019-09-30 $552
2019-06-30 $530
2019-03-31 $498
2018-12-31 $528
2018-09-30 $450
2018-06-30 $522
2018-03-31 $382
2017-12-31 $444
2017-09-30 $382
2017-06-30 $326
2017-03-31 $384
2016-12-31 $326
2016-09-30 $269
2016-06-30 $246
2016-03-31 $263
2015-12-31 $244
2015-09-30 $188
2015-06-30 $163
2015-03-31 $159
2014-12-31 $124
2014-09-30 $198
2014-06-30 $100
2014-03-31 $90
2013-12-31 $97
2013-09-30 $85
2013-06-30 $102
2013-03-31 $71
2012-12-31 $114
2012-09-30 $60
2012-06-30 $87
2012-03-31 $36
2011-12-31 $29
2011-09-30 $17
2011-06-30 $17
2011-03-31 $32
2010-12-31 $86
2010-09-30 $17
2010-06-30 $50
2010-03-31 $17
2009-12-31 $7
2009-09-30 $1
2009-06-30 $1
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $12.104B $4.241B
Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. The company conducts its European clinical development operations in Geneva, Switzerland. Incyte's lead drug, Jakafi (ruxolitinib), is a first-in-class JAK1/JAK2 inhibitor, approved in the United States for the treatment of patients with polycythemia vera ('PV'),who have had an inadequate response to or are intolerant to hydroxyurea. It is also approved for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-PV MF, and post-essential thrombocythemia MF. The drug is also approved in the United States for treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients aged 12 years or older.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) GB $224.654B 16.77
Amgen (AMGN) US $151.198B 13.55
Gilead Sciences (GILD) US $129.098B 13.40
Vertex Pharmaceuticals (VRTX) US $128.836B 0.00
Bristol Myers Squibb (BMY) US $102.914B 6.89
GSK (GSK) GB $80.610B 9.58
CSL (CSLLY) AU $80.379B 0.00
Regeneron Pharmaceuticals (REGN) US $66.208B 15.87
Argenex SE (ARGX) NL $39.669B 272.97
Alnylam Pharmaceuticals (ALNY) US $33.821B 0.00
BeiGene (ONC) KY $25.298B 0.00
BioNTech SE (BNTX) DE $25.183B 0.00
Biogen (BIIB) US $18.101B 7.81
Genmab (GNMSF) DK $14.542B 14.98
Genmab (GMAB) DK $13.773B 17.32
Insmed (INSM) US $13.146B 0.00
Illumina (ILMN) US $12.326B 31.79
BioMarin Pharmaceutical (BMRN) US $11.836B 19.32
Exelixis (EXEL) US $10.913B 22.63
Swedish Orphan Biovitrum (BIOVF) SE $10.858B 27.73
Moderna (MRNA) US $10.678B 0.00
Ascendis Pharma (ASND) DK $10.491B 0.00
Exact Sciences (EXAS) US $9.724B 0.00
QIAGEN (QGEN) NL $9.587B 19.30
Roivant Sciences (ROIV) GB $8.192B 0.00
Bio-Techne Corp (TECH) US $7.982B 30.60
Repligen (RGEN) US $7.946B 89.00
Revolution Medicines (RVMD) US $7.585B 0.00
Halozyme Therapeutics (HALO) US $7.559B 15.61
Jazz Pharmaceuticals (JAZZ) IE $7.399B 6.59
TG Therapeutics (TGTX) US $6.897B 310.29
Blueprint Medicines (BPMC) US $6.758B 0.00
Bio-Rad Laboratories (BIO.B) US $6.566B 22.20
Telix Pharmaceuticals (TLX) AU $6.318B 0.00
Sarepta Therapeutics (SRPT) US $6.240B 29.00
Verona Pharma American Depositary Share (VRNA) GB $6.181B 0.00
Legend Biotech (LEGN) US $6.092B 0.00
Guardant Health (GH) US $5.804B 0.00
ADMA Biologics Inc (ADMA) US $5.589B 47.04
Nuvalent (NUVL) US $5.546B 0.00
Axsome Therapeutics (AXSM) US $5.523B 0.00
Zealand Pharma (ZLDPF) DK $5.337B 0.00
Alkermes (ALKS) IE $5.241B 14.06
Krystal Biotech (KRYS) US $4.802B 50.05
Vaxcyte (PCVX) US $4.565B 0.00
Cytokinetics (CYTK) US $4.452B 0.00
Rhythm Pharmaceuticals (RYTM) US $4.071B 0.00
PTC Therapeutics (PTCT) US $3.958B 0.00
Avidity Biosciences (RNA) US $3.881B 0.00
Ultragenyx Pharmaceutical (RARE) US $3.690B 0.00
Arcellx (ACLX) US $3.610B 0.00
Akero Therapeutics (AKRO) US $3.575B 0.00
SpringWorks Therapeutics (SWTX) US $3.467B 0.00
Zai Lab (ZLAB) CN $3.440B 0.00
CRISPR Therapeutics AG (CRSP) CH $3.303B 0.00
Viking Therapeutics (VKTX) US $3.297B 0.00
Scholar Rock Holding (SRRK) US $3.122B 0.00
Merus (MRUS) NL $3.057B 0.00
Xenon Pharmaceuticals (XENE) CA $2.932B 0.00
Protagonist Therapeutics (PTGX) US $2.820B 10.84
MoonLake Immunotherapeutics (MLTX) CH $2.709B 0.00
Metsera (MTSR) US $2.695B 0.00
Immunovant (IMVT) US $2.684B 0.00
HUTCHMED (China) (HCM) HK $2.615B 0.00
Apellis Pharmaceuticals (APLS) US $2.556B 0.00
ACADIA Pharmaceuticals (ACAD) US $2.495B 22.25
Alvotech (ALVO) LU $2.478B 0.00
Denali Therapeutics (DNLI) US $2.388B 0.00
Twist Bioscience (TWST) US $2.341B 0.00
Biohaven (BHVN) US $2.332B 0.00
Kymera Therapeutics (KYMR) US $2.297B 0.00
ImmunityBio (IBRX) US $2.242B 0.00
Ascentage Pharma Group - (AAPG) CN $2.219B 0.00
CG Oncology (CGON) US $2.214B 0.00
Mirum Pharmaceuticals (MIRM) US $2.161B 0.00
Ligand Pharmaceuticals (LGND) US $2.109B 0.00
Certara (CERT) US $2.098B 44.79
Amicus Therapeutics (FOLD) US $2.054B 222.33
Beam Therapeutics (BEAM) US $2.035B 0.00
NovoCure (NVCR) JE $2.023B 0.00
Kiniksa Pharmaceuticals (KNSA) GB $2.009B 0.00
Belite Bio (BLTE) US $1.995B 0.00
Tarsus Pharmaceuticals (TARS) US $1.990B 0.00
Arrowhead Pharmaceuticals (ARWR) US $1.980B 0.00
Vericel (VCEL) US $1.953B 216.39
Janux Therapeutics (JANX) US $1.945B 0.00
Bavarian Nordic (BVNRY) DK $1.897B 13.37
Travere Therapeutics (TVTX) US $1.878B 0.00
IDEAYA Biosciences (IDYA) US $1.833B 0.00
Arcutis Biotherapeutics (ARQT) US $1.817B 0.00
Apogee Therapeutics (APGE) US $1.801B 0.00
Edgewise Therapeutics (EWTX) US $1.772B 0.00
Agios Pharmaceuticals (AGIO) US $1.743B 0.00
Harmony Biosciences Holdings (HRMY) US $1.740B 12.08
Disc Medicine (IRON) US $1.712B 0.00
Vera Therapeutics (VERA) US $1.613B 0.00
ANI Pharmaceuticals (ANIP) US $1.588B 17.97
Structure Therapeutics (GPCR) US $1.553B 0.00
Mesoblast (MESO) AU $1.540B 0.00
Immunocore Holdings (IMCR) GB $1.525B 0.00
MannKind (MNKD) US $1.519B 31.25
Adaptive Biotechnologies (ADPT) US $1.495B 0.00
Dynavax Technologies (DVAX) US $1.387B 62.94
Celldex Therapeutics (CLDX) US $1.372B 0.00
Liquidia Technologies (LQDA) US $1.353B 0.00
89BIO (ETNB) US $1.274B 0.00
GRAIL (GRAL) US $1.263B 0.00
WAVE Life Sciences (WVE) SG $1.248B 0.00
Pacira BioSciences (PCRX) US $1.224B 11.50
Syndax Pharmaceuticals (SNDX) US $1.181B 0.00
Iovance Biotherapeutics (IOVA) US $1.169B 0.00
BGM Group (BGM) CN $1.138B 0.00
Viridian Therapeutics (VRDN) US $1.111B 0.00
Novavax (NVAX) US $1.031B 0.00
Mineralys Therapeutics (MLYS) US $1.000B 0.00
NeoGenomics (NEO) US $0.991B 0.00
Arcus Biosciences (RCUS) US $0.966B 0.00
Pharvaris (PHVS) NL $0.961B 0.00
MiMedx (MDXG) US $0.933B 22.57
Anbio Biotechnology (NNNN) DE $0.925B 0.00
Intellia Therapeutics (NTLA) US $0.916B 0.00
Spyre Therapeutics (SYRE) US $0.911B 0.00
Zymeworks (ZYME) US $0.902B 0.00
Geron (GERN) US $0.879B 0.00
Gyre Therapeutics (GYRE) US $0.868B 115.75
Nurix Therapeutics (NRIX) US $0.859B 0.00
Rocket Pharmaceuticals (RCKT) US $0.855B 0.00
Vir Biotechnology (VIR) US $0.850B 0.00
Nuvation Bio (NUVB) US $0.833B 0.00
Oculis Holding AG (OCS) CH $0.824B 0.00
Praxis Precision Medicines (PRAX) US $0.820B 0.00
LENZ Therapeutics (LENZ) US $0.813B 0.00
UniQure (QURE) NL $0.809B 0.00
Day One Biopharmaceuticals (DAWN) US $0.804B 0.00
Anavex Life Sciences (AVXL) US $0.799B 0.00
CureVac (CVAC) DE $0.799B 4.34
Regencell Bioscience Holdings (RGC) HK $0.797B 0.00
Bicara Therapeutics (BCAX) US $0.791B 0.00
Replimune (REPL) US $0.771B 0.00
Immunome (IMNM) US $0.770B 0.00
ArriVent BioPharma (AVBP) US $0.725B 0.00
AbCellera Biologics (ABCL) CA $0.719B 0.00
Trevi Therapeutics (TRVI) US $0.698B 0.00
Dianthus Therapeutics (DNTH) US $0.697B 0.00
Myriad Genetics (MYGN) US $0.697B 0.00
Arbutus Biopharma (ABUS) US $0.687B 0.00
Cogent Biosciences (COGT) US $0.668B 0.00
Sinovac Biotech (SVA) CN $0.645B 0.00
Bicycle Therapeutics (BCYC) GB $0.644B 0.00
CorMedix Inc (CRMD) US $0.636B 0.00
Zhengye Biotechnology Holding (ZYBT) CN $0.636B 0.00
Immatics (IMTX) DE $0.636B 37.36
Niagen Bioscience (NAGE) US $0.629B 200.00
AnaptysBio (ANAB) US $0.627B 0.00
Basilea Pharmaceutica AG (BPMUF) CH $0.626B 0.00
Pharming Group (PHGUF) NL $0.613B 0.00
Pharming Group (PHAR) NL $0.610B 0.00
Sionna Therapeutics (SION) US $0.599B 0.00
Keros Therapeutics (KROS) US $0.595B 0.00
GH Research (GHRS) IE $0.593B 0.00
MeiraGTx Holdings (MGTX) US $0.580B 0.00
Tyra Biosciences (TYRA) US $0.577B 0.00
Fortrea Holdings (FTRE) US $0.567B 18.41
Arvinas (ARVN) US $0.563B 0.00
Kura Oncology (KURA) US $0.560B 0.00
Castle Biosciences (CSTL) US $0.558B 31.21
Urogen Pharma (URGN) US $0.531B 0.00
Stoke Therapeutics (STOK) US $0.526B 0.00
Opthea (OPT) AU $0.525B 0.00
Mind Medicine (MindMed) (MNMD) US $0.522B 0.00
REGENXBIO (RGNX) US $0.521B 0.00
Cullinan Therapeutics (CGEM) US $0.519B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) US $0.502B 0.00
Zenas BioPharma (ZBIO) US $0.499B 0.00
Cytek Biosciences (CTKB) US $0.493B 0.00
Maze Therapeutics (MAZE) US $0.475B 0.00
Eton Pharmaceuticals (ETON) US $0.465B 0.00
Upstream Bio (UPB) US $0.464B 0.00
Precigen (PGEN) US $0.463B 0.00
Prothena (PRTA) IE $0.458B 0.00
Sage Therapeutics (SAGE) US $0.457B 0.00
Abivax SA (ABVX) FR $0.456B 0.00
Erasca (ERAS) US $0.448B 0.00
Northwest Biotherapeutics (NWBO) US $0.432B 0.00
Sana Biotechnology (SANA) US $0.426B 0.00
Mereo BioPharma Group - (MREO) GB $0.425B 0.00
PureTech Health (PRTC) US $0.422B 0.00
Oxford BioMedica (OXBDF) GB $0.416B 0.00
Rapport Therapeutics (RAPP) US $0.414B 0.00
Celcuity (CELC) US $0.412B 0.00
Ginkgo Bioworks Holdings (DNA) US $0.409B 0.00
Tectonic Therapeutic (TECX) US $0.406B 0.00
Oric Pharmaceuticals (ORIC) US $0.403B 0.00
MBX Biosciences (MBX) US $0.401B 0.00
Absci (ABSI) US $0.386B 0.00
Olema Pharmaceuticals (OLMA) US $0.384B 0.00
Kamada (KMDA) IL $0.383B 25.61
Verastem (VSTM) US $0.383B 0.00
Allogene Therapeutics (ALLO) US $0.372B 0.00
Autolus Therapeutics (AUTL) GB $0.359B 0.00
Benitec Biopharma (BNTC) US $0.353B 0.00
Entrada Therapeutics (TRDA) US $0.350B 4.83
Alpha Teknova (TKNO) US $0.348B 0.00
Arcturus Therapeutics Holdings (ARCT) US $0.348B 0.00
Checkpoint Therapeutics (CKPT) US $0.345B 0.00
Solid Biosciences (SLDB) US $0.334B 0.00
Septerna (SEPN) US $0.333B 0.00
Cartesian Therapeutics (RNAC) US $0.329B 0.00
Abeona Therapeutics (ABEO) US $0.320B 0.00
ATyr Pharma (ATYR) US $0.320B 0.00
Aura Biosciences (AURA) US $0.309B 0.00
Monte Rosa Therapeutics (GLUE) US $0.306B 0.00
Terns Pharmaceuticals (TERN) US $0.306B 0.00
Fulcrum Therapeutics (FULC) US $0.303B 0.00
Astria Therapeutics (ATXS) US $0.302B 0.00
MaxCyte (MXCT) US $0.300B 0.00
ITeos Therapeutics (ITOS) US $0.297B 0.00
XOMA Royalty (XOMA) US $0.291B 0.00
Emergent Biosolutions (EBS) US $0.279B 0.00
Aardvark Therapeutics (AARD) US $0.279B 0.00
Monopar Therapeutics (MNPR) US $0.275B 0.00
Cidara Therapeutics (CDTX) US $0.272B 0.00
Palvella Therapeutics (PVLA) US $0.270B 0.00
Lifecore Biomedical (LFCR) US $0.270B 0.00
Vanda Pharmaceuticals (VNDA) US $0.269B 0.00
Gossamer Bio (GOSS) US $0.268B 0.00
2seventy Bio (TSVT) US $0.266B 0.00
Design Therapeutics (DSGN) US $0.264B 0.00
Compass Therapeutics (CMPX) US $0.261B 0.00
Candel Therapeutics (CADL) US $0.260B 0.00
ACELYRIN, INC (SLRN) US $0.259B 0.00
Atea Pharmaceuticals (AVIR) US $0.255B 0.00
Kodiak Sciences (KOD) US $0.253B 0.00
Prima BioMed (IMMP) AU $0.250B 0.00
Corvus Pharmaceuticals (CRVS) US $0.247B 0.00
Lexicon Pharmaceuticals (LXRX) US $0.246B 0.00
DBV Technologies S.A (DBVT) FR $0.245B 0.00
Rezolute (RZLT) US $0.242B 0.00
Neurogene (NGNE) US $0.242B 0.00
Foghorn Therapeutics (FHTX) US $0.236B 0.00
BioStem Technologies (BSEM) $0.234B 9.35
Third Harmonic Bio (THRD) US $0.233B 0.00
Bright Minds Biosciences (DRUG) US $0.227B 0.00
Amarin (AMRN) IE $0.226B 0.00
Ocugen (OCGN) US $0.223B 0.00
Prime Medicine (PRME) US $0.220B 0.00
Nuvectis Pharma (NVCT) US $0.218B 0.00
Alumis (ALMS) US $0.217B 0.00
Annexon (ANNX) US $0.216B 0.00
GENFIT S.A (GNFT) FR $0.214B 0.00
Adocia (ADOCY) FR $0.213B 0.00
Anika Therapeutics (ANIK) US $0.213B 0.00
ProQR Therapeutics (PRQR) NL $0.209B 0.00
Codexis (CDXS) US $0.209B 0.00
Actuate Therapeutics (ACTU) US $0.206B 0.00
Humacyte (HUMA) US $0.203B 0.00
Voyager Therapeutics (VYGR) US $0.201B 0.00
Y-mAbs Therapeutics (YMAB) US $0.200B 0.00
CARGO Therapeutics (CRGX) US $0.199B 0.00
Eledon Pharmaceuticals (ELDN) US $0.198B 0.00
EnGene Holdings (ENGN) CA $0.195B 0.00
Phathom Pharmaceuticals (PHAT) US $0.193B 0.00
Innate Pharma S.A (IPHA) FR $0.189B 0.00
Cardiff Oncology (CRDF) US $0.188B 0.00
Semper Paratus Acquisition (TVGN) US $0.186B 0.00
DiaMedica Therapeutics (DMAC) US $0.181B 0.00
INmune Bio (INMB) US $0.178B 0.00
Inventiva S.A (IVA) FR $0.177B 0.00
Inhibrx Biosciences (INBX) US $0.176B 0.00
Adherex Technologies (FENC) US $0.174B 0.00
AC Immune (ACIU) CH $0.173B 0.00
TuHURA Biosciences (HURA) US $0.171B 0.00
Sangamo Therapeutics (SGMO) US $0.167B 0.00
Molecular Partners AG (MOLN) CH $0.165B 0.00
Galena Biopharma (SLS) US $0.165B 0.00
Tango Therapeutics (TNGX) US $0.163B 0.00
Puma Biotechnology (PBYI) US $0.159B 5.26
BioAge Labs (BIOA) US $0.150B 0.00
Fate Therapeutics (FATE) US $0.150B 0.00
Tiziana Life Sciences (TLSA) GB $0.150B 0.00
Nkarta (NKTX) US $0.148B 0.00
Eupraxia Pharmaceuticals (EPRX) CA $0.144B 0.00
ADC Therapeutics SA (ADCT) CH $0.143B 0.00
Editas Medicine (EDIT) US $0.137B 0.00
Vigil Neuroscience (VIGL) US $0.135B 0.00
Greenwich LifeSciences (GLSI) US $0.133B 0.00
Compugen (CGEN) IL $0.132B 0.00
ScPharmaceuticals (SCPH) US $0.131B 0.00
Alector (ALEC) US $0.130B 0.00
Cuprina Holdings (Cayman) (CUPR) SG $0.128B 0.00
Rapt Therapeutics (RAPT) US $0.128B 0.00
Coherus BioSciences (CHRS) US $0.128B 0.00
Theratechnologies (THTX) CA $0.127B 0.00
Neumora Therapeutics (NMRA) US $0.126B 0.00
C4 Therapeutics (CCCC) US $0.124B 0.00
Seer (SEER) US $0.123B 0.00
Sagimet Biosciences (SGMT) US $0.117B 0.00
InflaRx (IFRX) DE $0.116B 0.00
Immunic (IMUX) US $0.110B 0.00
BioHarvest Sciences (BHST) CA $0.107B 0.00
Entera Bio (ENTX) IL $0.107B 0.00
Coya Therapeutics (COYA) US $0.107B 0.00
Contineum Therapeutics (CTNM) US $0.106B 0.00
Orchestra BioMed Holdings (OBIO) US $0.105B 0.00
Inozyme Pharma (INZY) US $0.105B 0.00
Zentalis Pharmaceuticals (ZNTL) US $0.104B 0.00
Pliant Therapeutics (PLRX) US $0.104B 0.00
Ventyx Biosciences (VTYX) US $0.103B 0.00
Alpha Cognition (ACOG) CA $0.102B 0.00
Black Diamond Therapeutics (BDTX) US $0.101B 0.00
Zura Bio (ZURA) US $0.101B 0.00
Genelux (GNLX) US $0.099B 0.00
Kyverna Therapeutics (KYTX) US $0.099B 0.00
HilleVax (HLVX) US $0.098B 0.00
Instil Bio (TIL) US $0.095B 0.00
Sutro Biopharma (STRO) US $0.093B 0.00
EXoZymes (EXOZ) US $0.091B 0.00
TScan Therapeutics (TCRX) US $0.091B 0.00
ANIXA BIOSCIENCES INC (ANIX) US $0.090B 0.00
CervoMed (CRVO) US $0.089B 0.00
XBiotech (XBIT) US $0.089B 0.00
Cellectis S.A (CLLS) FR $0.088B 0.00
Elicio Therapeutics (ELTX) US $0.088B 0.00
Senti Biosciences (SNTI) US $0.087B 0.00
Climb Bio (CLYM) US $0.086B 0.00
Nautilus Biotechnology (NAUT) US $0.085B 0.00
Seres Therapeutics (MCRB) US $0.084B 0.00
Elutia (ELUT) US $0.083B 0.00
Vor Biopharma (VOR) $0.083B 0.00
Biomea Fusion (BMEA) US $0.082B 0.00
Caribou Biosciences (CRBU) US $0.082B 0.00
Jasper Therapeutics (JSPR) US $0.081B 0.00
IGM Biosciences (IGMS) US $0.081B 0.00
I-Mab (IMAB) US $0.077B 0.00
Invivyd (IVVD) US $0.075B 0.00
MediciNova (MNOV) US $0.074B 0.00
Adaptimmune Therapeutics (ADAP) GB $0.074B 0.00
Adverum Biotechnologies (ADVM) US $0.073B 0.00
Genenta Science S.p.A (GNTA) IT $0.073B 0.00
Adagene (ADAG) CN $0.072B 0.00
VTv Therapeutics (VTVT) US $0.072B 0.00
Adlai Nortye (ANL) KY $0.071B 0.00
Inovio Pharmaceuticals (INO) US $0.070B 0.00
Milestone Pharmaceuticals (MIST) CA $0.070B 0.00
Skye Bioscience (SKYE) US $0.069B 0.00
VistaGen Therapeutics (VTGN) US $0.069B 0.00
BeyondSpring (BYSI) US $0.068B 0.00
Cabaletta Bio (CABA) US $0.068B 0.00
Exicure (XCUR) US $0.068B 0.00
Clearside Biomedical (CLSD) US $0.067B 0.00
IO Biotech (IOBT) DK $0.067B 0.00
Citius Oncology (CTOR) US $0.066B 0.00
Alto Neuroscience (ANRO) US $0.066B 0.00
Agenus (AGEN) US $0.066B 0.00
Acumen Pharmaceuticals (ABOS) US $0.065B 0.00
Applied Therapeutics (APLT) US $0.065B 0.00
Prenetics Global (PRE) HK $0.065B 0.00
CytomX Therapeutics (CTMX) US $0.065B 2.11
PDS Biotechnology (PDSB) US $0.063B 0.00
Rani Therapeutics Holdings (RANI) US $0.062B 0.00
Repare Therapeutics (RPTX) CA $0.061B 0.00
Akoya Biosciences (AKYA) US $0.061B 0.00
Achilles Therapeutics (ACHL) GB $0.061B 0.00
Precision BioSciences (DTIL) US $0.061B 0.00
Ikena Oncology (IKNA) US $0.060B 0.00
Artiva Biotherapeutics (ARTV) US $0.059B 0.00
Medicus Pharma (MDCX) US $0.059B 0.00
Immix Biopharma (IMMX) US $0.058B 0.00
Adicet Bio (ACET) US $0.055B 0.00
Fortress Biotech (FBIO) US $0.054B 0.00
Renovaro (RENB) US $0.053B 0.00
ZIVO Bioscience (ZIVO) US $0.053B 0.00
Cyclacel Pharmaceuticals (CYCC) US $0.052B 0.00
PepGen (PEPG) US $0.052B 0.00
Biodexa Pharmaceuticals (BDRX) GB $0.051B 0.00
Oncobiologics (OTLK) US $0.050B 0.00
Mersana Therapeutics (MRSN) US $0.050B 0.00
Shattuck Labs (STTK) US $0.048B 0.00
Oncolytics Biotech (ONCY) CA $0.048B 0.00
Anebulo Pharmaceuticals (ANEB) US $0.047B 0.00
Quince Therapeutics (QNCX) US $0.047B 0.00
Atara Biotherapeutics (ATRA) US $0.047B 0.00
Cue Biopharma (CUE) US $0.047B 0.00
OKYO Pharma (OKYO) $0.046B 0.00
Forte Biosciences (FBRX) US $0.046B 0.00
Connect Biopharma Holdings (CNTB) US $0.046B 0.00
Tenaya Therapeutics (TNYA) US $0.046B 0.00
Immuneering (IMRX) US $0.045B 0.00
Opus Genetics (IRD) US $0.043B 0.00
Kronos Bio (KRON) US $0.043B 0.00
Whitehawk Therapeutics (WHWK) US $0.043B 0.00
Advanced Biomed (ADVB) US $0.042B 0.00
Estrella Immunopharma (ESLA) US $0.042B 0.00
Tvardi Therapeutics (TVRD) US $0.041B 0.00
Werewolf Therapeutics (HOWL) US $0.041B 0.00
TELA Bio (TELA) US $0.040B 0.00
Rein Therapeutics (RNTX) US $0.040B 0.00
CAMP4 Therapeutics (CAMP) US $0.039B 0.00
Xilio Therapeutics (XLO) US $0.039B 0.00
Bluebird Bio (BLUE) US $0.039B 0.00
FibroBiologics (FBLG) US $0.039B 0.00
Lantern Pharma (LTRN) US $0.038B 0.00
Celularity (CELU) US $0.038B 0.00
Scilex Holding (SCLX) US $0.038B 0.00
Barinthus Biotherapeutics (BRNS) GB $0.037B 0.00
AN2 Therapeutics (ANTX) US $0.037B 0.00
Akari Therapeutics (AKTX) GB $0.037B 0.00
RenovoRx (RNXT) US $0.037B 0.00
Spero Therapeutics (SPRO) US $0.036B 0.00
Dyadic (DYAI) US $0.036B 0.00
Boundless Bio (BOLD) US $0.036B 0.00
Pluri (PLUR) IL $0.034B 0.00
Aligos Therapeutics (ALGS) US $0.034B 0.00
LAVA Therapeutics (LVTX) NL $0.034B 0.00
OnKure Therapeutics (OKUR) US $0.034B 0.00
Kezar Life Sciences (KZR) US $0.033B 0.00
BioAtla (BCAB) US $0.033B 0.00
Cadrenal Therapeutics (CVKD) US $0.032B 0.00
Femasys (FEMY) US $0.032B 0.00
Radiopharm Theranostics - (RADX) AU $0.031B 0.00
Grace Therapeutics (GRCE) CA $0.031B 0.00
Alterity Therapeutics - (ATHE) AU $0.031B 0.00
MiNK Therapeutics (INKT) US $0.030B 0.00
Allakos (ALLK) US $0.029B 0.00
Kalaris Therapeutics (KLRS) US $0.029B 0.00
Generation Bio (GBIO) US $0.029B 0.00
ALX Oncology Holdings (ALXO) US $0.028B 0.00
Cognition Therapeutics (CGTX) US $0.028B 0.00
Coeptis Therapeutics Holdings (COEP) US $0.027B 0.00
Clene (CLNN) US $0.027B 0.00
Dare Bioscience (DARE) US $0.026B 0.00
CollPlant Biotechnologies (CLGN) IL $0.025B 0.00
Passage Bio (PASG) US $0.025B 0.00
CalciMedica (CALC) US $0.024B 0.00
KALA BIO (KALA) US $0.024B 0.00
Tenax Therapeutics (TENX) US $0.024B 0.00
Longeveron (LGVN) US $0.023B 0.00
Ovid Therapeutics (OVID) US $0.023B 0.00
Annovis Bio (ANVS) US $0.023B 0.00
Cardio Diagnostics Holdings (CDIO) US $0.022B 0.00
X4 Pharmaceuticals (XFOR) US $0.022B 0.00
Quantum Biopharma (QNTM) CA $0.021B 0.00
Promis Neurosciences (PMN) CA $0.021B 0.00
Lexaria Bioscience (LEXX) CA $0.021B 0.00
Lisata Therapeutics (LSTA) US $0.021B 0.00
Elevation Oncology (ELEV) US $0.021B 0.00
Curis (CRIS) US $0.020B 0.00
Chemomab Therapeutics (CMMB) IL $0.020B 0.00
Q32 Bio (QTTB) US $0.020B 0.00
MIRA Pharmaceuticals (MIRA) US $0.020B 0.00
UNITY Biotechnology (UBX) US $0.019B 0.00
Allarity Therapeutics (ALLR) US $0.019B 0.00
ABVC BioPharma (ABVC) US $0.018B 0.00
Beyond Air (XAIR) US $0.018B 0.00
Gelteq (GELS) AU $0.017B 0.00
Leap Therapeutics (LPTX) US $0.017B 0.00
Cingulate (CING) US $0.017B 0.00
Edesa Biotech (EDSA) CA $0.017B 0.00
Aspire Biopharma Holdings (ASBP) US $0.017B 0.00
HOOKIPA Pharma (HOOK) US $0.016B 0.00
Affimed (AFMD) DE $0.015B 0.00
GeoVax Labs (GOVX) US $0.015B 0.00
Equillium (EQ) US $0.015B 0.00
SAB Biotherapeutics (SABS) US $0.015B 0.00
BRIACELL THERAP (BCTX) CA $0.015B 0.00
Moleculin Biotech (MBRX) US $0.014B 0.00
NeuroSense Therapeutics (NRSN) IL $0.014B 0.00
Synlogic (SYBX) US $0.014B 0.00
Biorestorative Therapies (BRTX) US $0.014B 0.00
IN8bio (INAB) US $0.014B 0.00
BioCardia (BCDA) US $0.014B 0.00
Bolt Biotherapeutics (BOLT) US $0.014B 0.00
Rallybio (RLYB) US $0.013B 0.00
Bionano Genomics (BNGO) US $0.013B 0.00
NextCure (NXTC) US $0.012B 0.00
Imunon (IMNN) US $0.012B 0.00
Abpro Holdings (ABP) US $0.012B 0.00
Hoth Therapeutics (HOTH) US $0.012B 0.00
COSCIENS Biopharma (CSCI) CA $0.012B 0.00
Athira Pharma (ATHA) US $0.011B 0.00
IMMURON (IMRN) AU $0.011B 0.00
LakeShore Biopharma (LSB) CN $0.011B 0.00
Portage Biotech (PRTG) $0.011B 0.00
Sensei Biotherapeutics (SNSE) US $0.011B 0.00
Aerovate Therapeutics (JBIO) US $0.010B 0.00
Aprea Therapeutics (APRE) US $0.010B 0.00
Cyclerion Therapeutics (CYCN) US $0.010B 0.00
IBio (IBIO) US $0.010B 0.00
BioXcel Therapeutics (BTAI) US $0.010B 0.00
Dogwood Therapeutics (DWTX) US $0.010B 0.00
Acurx Pharmaceuticals (ACXP) US $0.009B 0.00
Neuphoria Therapeutics (NEUP) AU $0.009B 0.00
Creative Medical Technology Holdings (CELZ) US $0.009B 0.00
Intensity Therapeutics (INTS) US $0.009B 0.00
Silexion Therapeutics Corp (SLXN) IL $0.009B 0.00
HCW Biologics (HCWB) US $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) US $0.008B 0.00
BioAffinity Technologies (BIAF) US $0.008B 0.00
Turnstone Biologics (TSBX) US $0.008B 0.00
Aytu BioPharma (AYTU) US $0.008B 0.00
GENPREX (GNPX) US $0.007B 0.00
Apollomics (APLM) US $0.007B 0.00
Biofrontera (BFRI) US $0.007B 0.00
MetaVia (MTVA) US $0.007B 0.00
Mainz Biomed (MYNZ) DE $0.007B 0.00
Lipella Pharmaceuticals (LIPO) US $0.006B 0.00
Avalon GloboCare (ALBT) US $0.006B 0.00
Evogene (EVGN) IL $0.006B 0.00
180 Life Sciences (ATNF) US $0.006B 0.00
GT Biopharma (GTBP) US $0.006B 0.00
Dermata Therapeutics (DRMA) US $0.005B 0.00
Soligenix (SNGX) US $0.005B 0.00
Arcadia Biosciences (RKDA) US $0.005B 0.00
Onconetix (ONCO) US $0.005B 0.00
Alzamend Neuro (ALZN) US $0.004B 0.00
Adial Pharmaceuticals (ADIL) US $0.004B 0.00
Polyrizon (PLRZ) IL $0.004B 0.00
Ensysce Biosciences (ENSC) US $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) US $0.004B 0.00
Pasithea Therapeutics (KTTA) US $0.004B 0.00
Galecto (GLTO) DK $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) US $0.004B 0.00
Novogen (KZIA) AU $0.004B 0.00
VivoSim Labs (VIVS) US $0.004B 0.00
Sunshine Biopharma (SBFM) US $0.004B 0.00
Windtree Therapeutics (WINT) US $0.004B 0.00
Mustang Bio (MBIO) US $0.004B 0.00
Palisade Bio (PALI) US $0.003B 0.00
Titan Pharmaceuticals (TTNP) US $0.003B 0.00
Tharimmune (THAR) US $0.003B 0.00
Silo Pharma (SILO) US $0.003B 0.00
Synaptogenix (SNPX) US $0.003B 0.00
Artelo Biosciences (ARTL) US $0.003B 0.00
CNS Pharmaceuticals (CNSP) US $0.003B 0.00
Eyenovia (EYEN) US $0.003B 0.00
Virax Biolabs Group (VRAX) GB $0.003B 0.00
Enveric Biosciences (ENVB) US $0.003B 0.00
Hepion Pharmaceuticals (HEPA) US $0.003B 0.00
Purple Biotech (PPBT) IL $0.003B 0.00
Aptevo Therapeutics (APVO) US $0.003B 0.00
NuCana (NCNA) GB $0.003B 0.00
Scinai Immunotherapeutics (SCNI) IL $0.003B 0.00
Revelation Biosciences (REVB) US $0.003B 0.00
AquaBounty Technologies (AQB) US $0.003B 0.00
Bone Biologics (BBLG) US $0.002B 0.00
Evaxion Biotech (EVAX) DK $0.002B 0.00
Psyence Biomedical (PBM) CA $0.002B 0.00
Atrinsic (PTIX) US $0.002B 0.00
Entero Therapeutics (ENTO) US $0.002B 0.00
ZyVersa Therapeutics (ZVSA) US $0.002B 0.00
NAYA Biosciences (IVF) US $0.001B 0.00
GRI Bio (GRI) US $0.001B 0.00
Capstone Therapeutics (CAPS) US $0.000B 0.00
TFF Pharmaceuticals (TFFP) US $0.000B 0.00
Aceragen (ACGN) US $0.000B 0.00
ARAVIVE, INC (ARAV) US $0.000B 0.00
Clovis Oncology (CLVSQ) US $0.000B 0.00
Cocrystal Pharma (COCP) US $0.000B 0.00
Celyad SA (CYAD) BE $0.000B 0.00
CytoMed Therapeutics (GDTC) SG $0.000B 0.00
Galapagos (GLPG) BE $0.000B 0.00
Motif Bio Plc (MTFB) GB $0.000B 0.00
PDL BioPharma (PDLI) US $0.000B 0.00
Pulmatrix (PULM) US $0.000B 0.00
VectivBio Holding AG (VECT) CH $0.000B 0.00